Brain gene therapy with Trojan horse lipid nanoparticles

Area of Science:

• Biotechnology
• Neuroscience
• Gene Therapy

Background:

• Lipid nanoparticles (LNPs) are crucial for mRNA vaccine delivery.
• Nucleic acid delivery technologies offer potential for gene therapy.
• Efficient delivery across the blood-brain barrier (BBB) is a major challenge for brain gene therapy.

Purpose of the Study:

• To propose a novel strategy for delivering gene therapy agents across the BBB.
• To explore the use of receptor-specific monoclonal antibodies (MAbs) for enhanced LNP brain delivery.

Main Methods:

• Reformulating LNPs by conjugating MAbs to their surface.
• Utilizing MAbs as molecular Trojan horses to trigger receptor-mediated transcytosis (RMT) across the BBB.

Main Results:

• The proposed MAb-conjugated LNPs are designed to cross the BBB.
• Successful BBB transcytosis would lead to LNP localization in the brain nucleus.
• This facilitates transcription of therapeutic genes for brain conditions.

Conclusions:

• MAb-conjugated LNPs represent a promising approach for brain gene therapy.
• This strategy could overcome the BBB challenge, enabling new therapeutic interventions.
• Trojan horse LNPs offer a potential pathway for treating neurological disorders.